High Mark Wealth Management LLC Macrogenics Inc Transaction History
High Mark Wealth Management LLC
- $182 Million
- Q3 2024
A detailed history of High Mark Wealth Management LLC transactions in Macrogenics Inc stock. As of the latest transaction made, High Mark Wealth Management LLC holds 400 shares of MGNX stock, worth $1,548. This represents 0.0% of its overall portfolio holdings.
Number of Shares
400
Previous 400
-0.0%
Holding current value
$1,548
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding MGNX
# of Institutions
151Shares Held
60.3MCall Options Held
218KPut Options Held
259K-
Bellevue Group Ag Kuesnacht, V89.94MShares$38.5 Million0.71% of portfolio
-
Armistice Capital, LLC New York, NY6MShares$23.2 Million0.33% of portfolio
-
Black Rock Inc. New York, NY5.4MShares$20.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.14MShares$16 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.31MShares$12.8 Million0.01% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $238M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...